GlassScriptPhysician profile
Muriel Guigui
NPI 1619068335
$8,002.05
in general payments reported to CMS, 2019-2025
20 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,413 · 2022: $808 · 2023: $2,410 · 2024: $1,646 · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,764 · Education: $16.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,763.70 |
| Education | $16.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,249.48 | 2021-2023 | Krystexxa |
| Abbvie INC. | $1,037.32 | 2021-2025 | |
| Amgen INC. | $885.22 | 2021-2025 | Krystexxa, Enbrel, Tavneos |
| Ucb, INC. | $544.36 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $529.98 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $491.94 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $423.02 | 2021-2025 | Benlysta |
| Janssen Biotech, INC. | $418.29 | 2022-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $394.02 | 2021-2025 | Orencia |
| Aurinia Pharma U.S., INC. | $331.07 | 2021-2023 | Lupkynis |
| Mallinckrodt Hospital Products INC. | $296.47 | 2023-2025 | Acthar |
| Radius Health, INC. | $278.77 | 2021-2025 | Tymlos |
| Alvogen INC | $233.18 | 2022-2024 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $187.95 | 2023-2025 | Strensiq |
| Ani Pharmaceuticals, INC. | $170.67 | 2023-2024 | Purified Cortrophin Gel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $160.74 | 2023-2025 | |
| Lilly USA, LLC | $135.93 | 2023-2024 | Taltz |
| Depuy Synthes Sales INC. | $125.36 | 2022-2024 | Orthovisc |
| Pfizer INC. | $94.81 | 2023-2024 | |
| Cardinal Health 108 LLC | $13.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muriel Guigui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.